BioSpace News Archive

Ayala Pharmaceuticals, Inc. today reported financial results for the period ended June 30, 2021 and highlighted recent progress and upcoming milestones for its pipeline programs.

PMV Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided corporate highlights.

Outlook Therapeutics, Inc. today announced recent corporate highlights and financial results for its fiscal third quarter ended June 30, 2021.

Alimera Sciences, Inc. today announced financial results for the second quarter of 2021. Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results.

Chemomab Therapeutics Ltd today announced financial and operating results for the second quarter ended June 30, 2021 and provided a business update.

Recro Pharma, Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced its acquisition of IRISYS, a San Diego-based CDMO that possesses capabilities that complement and expand those of Recro.

In an effort to better understand inflammation within the body, researchers at The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – successfully controlled the neurons that release molecular proteins and turn on/off inflammation.

A breast ultrasound is an imaging method primarily used to screen for tumors and other breast abnormalities.

The National Kidney Foundation (NKF) applauds the Food and Drug Administration (FDA) for amending the emergency use authorizations for the Pfizer and the Moderna COVID-19 vaccines to allow people who are immune compromised to receive a third dose.

Increase in number of malnutrition cases, growth in incidences of chronic illness, and high adoption of enteral nutrition over parenteral nutrition drive the growth of the global enteral nutrition market.